Dr. Catherine Miranda, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,530 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $497.65 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $164.22 | 7 | $0 (2024) |
| Vifor Pharma, Inc. | $139.70 | 5 | $0 (2024) |
| Mallinckrodt LLC | $118.88 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $113.02 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $112.55 | 5 | $0 (2024) |
| Amgen Inc. | $78.09 | 3 | $0 (2024) |
| ABBVIE INC. | $68.92 | 4 | $0 (2024) |
| Ardelyx, Inc. | $52.95 | 2 | $0 (2024) |
| Travere Therapeutics, Inc. | $44.04 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $748.23 | 24 | AstraZeneca Pharmaceuticals LP ($222.03) |
| 2023 | $313.95 | 8 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2022 | $348.75 | 13 | AstraZeneca Pharmaceuticals LP ($150.62) |
| 2017 | $118.88 | 1 | Mallinckrodt LLC ($118.88) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: Hyperkalemia | ||||||
| 11/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $1.65 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.45 | General |
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.08 | General |
| Category: Cardio-renal | ||||||
| 07/02/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEPHROLOGY | ||||||
| 06/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $97.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: Cardio-renal | ||||||
| 05/07/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Cardio-renal | ||||||
| 04/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $28.97 | General |
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.54 | General |
| 02/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Cardio-renal | ||||||
| 02/01/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $30.06 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,166 | 2,015 | $775,429 | $208,973 |
| 2022 | 7 | 1,073 | 1,920 | $734,107 | $198,525 |
| 2021 | 5 | 1,004 | 1,913 | $691,739 | $196,141 |
| 2020 | 8 | 822 | 1,389 | $532,933 | $140,881 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 354 | 657 | $266,742 | $72,640 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 394 | 807 | $217,890 | $59,384 | 27.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 287 | 302 | $178,482 | $47,782 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 186 | $82,212 | $20,927 | 25.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 12 | 38 | $13,756 | $3,771 | 27.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 12 | $8,820 | $2,416 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,527 | $2,053 | 27.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 473 | 1,039 | $364,689 | $100,069 | 27.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 251 | 259 | $176,379 | $47,076 | 26.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 225 | 403 | $98,735 | $27,129 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 157 | $70,022 | $17,689 | 25.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 12 | 36 | $8,604 | $2,365 | 27.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $7,956 | $2,206 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $7,722 | $1,991 | 25.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 431 | 953 | $321,161 | $92,243 | 28.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 213 | 234 | $155,376 | $43,459 | 28.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 257 | 526 | $124,662 | $35,888 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 180 | $79,020 | $21,243 | 26.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $11,520 | $3,308 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 347 | 696 | $255,432 | $67,704 | 26.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 151 | 154 | $110,418 | $28,572 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 172 | 290 | $73,950 | $19,507 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 148 | $57,720 | $14,526 | 25.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 12 | 37 | $11,914 | $3,160 | 26.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $10,674 | $2,803 | 26.3% |
About Dr. Catherine Miranda, M.D
Dr. Catherine Miranda, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2011. The National Provider Identifier (NPI) number assigned to this provider is 1497045942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Miranda, M.D has received a total of $1,530 in payments from pharmaceutical and medical device companies, with $748.23 received in 2024. These payments were reported across 46 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,530).
As a Medicare-enrolled provider, Miranda has provided services to 4,065 Medicare beneficiaries, totaling 7,237 services with total Medicare billing of $744,520. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Stony Brook, NY
- Active Since 04/18/2011
- Last Updated 04/18/2011
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1497045942
Products in Payments
- LOKELMA (Drug) $249.99
- FARXIGA (Drug) $247.66
- Kerendia (Drug) $164.22
- Veltassa (Drug) $139.70
- ACTHAR (Biological) $118.88
- JYNARQUE (Drug) $112.55
- IBSRELA (Drug) $52.95
- KRYSTEXXA (Biological) $45.87
- JARDIANCE (Drug) $40.45
- BENLYSTA (Biological) $39.25
- AVYCAZ (Drug) $34.04
- TAVNEOS (Drug) $32.22
- Velphoro (Drug) $23.20
- INJECTAFER (Drug) $18.50
- GATTEX (Drug) $18.39
- DALVANCE (Drug) $17.81
- TEFLARO (Drug) $17.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Stony Brook
Noreen Bukhari-Parlakturk, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $26,258
Aadit Shah, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $18,802
Kristine Jang, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $18,437
Mr. Stuart Drew
Student in an Organized Health Care Education/Training Program — Payments: $10,662
Dr. Brian Mccormack, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $9,541
Sonya Marcus, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,616